跳至主要内容
临床试验/JPRN-UMIN000017592
JPRN-UMIN000017592已完成未知

The effect of the cognitive function of GLP-1 receptor agonist in Type 2 diabtes patients with mild cognitive dysfunction. - prospective,randomized,active-controlled study - - GLP-1 receptor agonist in Type 2 diabtes patients with mild cognitive dysfunction. - prospective,randomized,active-controlled study

Tokyo medical university, Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Department of Gerontology0 个研究点目标入组 40 人开始时间: 2015年7月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients who are not Type 2 diabetes 2.Excessive common custom drinker 3.Patients having a cancer 4. Patients with severe diabetic complication. 5.Patients with severe renal disease or severe liver disease 6. History of chemical sensitivity to antidiabetic drugs. 7. Women who are pregnant or nursing or could become pregnant. 8. Determined to be ineligible by the physician in charge for any other reason.

研究者

发起方
Tokyo medical university, Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Department of Gerontology

相似试验